Pleiotropic effects of fenofibrate: focus on type 2 diabetes mellitus

Pleiotropic effects of fenofibrate: focus on type 2 diabetes mellitus

Aims. The aim of the present study was to investigate the role of chronic low-grade inflammation in the development of the diabetic neuropathy and the possibility of its medical treatment with fenofibrate (145 mg/day). Materials and Methods. This trial included 60 patients with type 2 diabetes...

Full description

Bibliographic Details
Main Authors:	Alexander Sergeevich Ametov, Marina Alexandrovna Prudnikova
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2014-09-01
Series:	Сахарный диабет
Subjects:	diabetes mellitus low-grade inflammation neuropathy fenofibrate
Online Access:	https://dia-endojournals.ru/dia/article/viewFile/6669/4779

Similar Items

Prospects for the management of diabetic neuropathy
by: Alexandr Sergeevich Ametov, et al.
Published: (2011-06-01)

Effects of fenofibrate in patients with type 2 diabetes mellitus complicated by diabetic neuropathy
by: Olga Nikolaevna Tkacheva, et al.
Published: (2010-03-01)

Fenofibrate decreased microalbuminuria in the type 2 diabetes patients with hypertriglyceridemia
by: Xiaomeng Sun, et al.
Published: (2020-05-01)

Fenofibrate decreases the bone quality by down regulating Runx2 in high-fat-diet induced Type 2 diabetes mellitus mouse model
by: Tianshu Shi, et al.
Published: (2017-10-01)

Neither polyphenol-rich red wine nor fenofibrate affects the onset of type-1 diabetes mellitus in the BB rat
by: Karin Åvall, et al.
Published: (2018-12-01)

Association of Fenofibrate and Diabetic Retinopathy in Type 2 Diabetic Patients: A Population-Based Retrospective Cohort Study in Taiwan
by: Ying-Chieh Lin, et al.
Published: (2020-07-01)

Comparison of efficacy and safety of choline fenofibrate (fenofibric acid) to micronized fenofibrate in patients of mixed dyslipidemia: A randomized, open-label, multicenter clinical trial in Indian population
by: Piyush Patel, et al.
Published: (2016-01-01)

A Fenofibrate Diet Prevents Paclitaxel-Induced Peripheral Neuropathy in Mice
by: Martial Caillaud, et al.
Published: (2021-12-01)

Effect of Fenofibrate on Hippocampal Insulin Resistance and Cognitive Function in a Rat Model of Type 2 Diabetes Mellitus
by: Olumayowa Kolawole Idowu, et al.
Published: (2021-01-01)

A comparative study of efficacy of atorvastatin alone and its combination with fenofibrate on lipid profile in type 2 diabetes mellitus patients with hyperlipidemia
by: Meenakshi Lella, et al.
Published: (2013-01-01)

PLEIOTROPIC EFFECTS OF SIMVASTATIN AND FENOFIBRATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A COMPARATIVE STUDY
by: I. V. Shirinsky, et al.
Published: (2019-01-01)

Efficiency of fenofibrate in facilitating the reduction of central macular thickness in diabetic macular edema
by: Srilakshmi Srinivasan, et al.
Published: (2018-01-01)

Development and validation of bioanalytical UHPLC-UV method for simultaneous analysis of unchanged fenofibrate and its metabolite fenofibric acid in rat plasma: Application to pharmacokinetics
by: Rayan G. Alamri, et al.
Published: (2017-01-01)

Fenofibrate improves vascular endothelial function in diabetic mice
by: Rujuan Xin, et al.
Published: (2019-04-01)

Comparison of efficacy and safety of fixed dose combination of rosuvastatin and choline fenofibrate to fixed dose combination of rosuvastatin and fenofibrate in patients of mixed dyslipidemia: A randomized, open-label, multicentre clinical trial in Indian population
by: Hanmant Barkate, et al.
Published: (2018-01-01)

Fenofibrate-induced renal dysfunction, yes or no?
by: Fatemeh Emami, et al.
Published: (2020-01-01)

Effect of fenofibrate on microcirculation and wound healing in healthy and diabetic mice
by: Valentin S, et al.
Published: (2009-02-01)

Treatment of chronic hemodialysis patients with low-dose fenofibrate effectively reduces plasma lipids and affects plasma redox status
by: Makówka Agnieszka, et al.
Published: (2012-07-01)

Osteoporosis and diabetes mellitus: a modern viewpoint
by: Natalya Alexandrovna Molitvoslovova, et al.
Published: (2013-03-01)

Protective Effect of Fenofibrate on Oxidative Stress-Induced Apoptosis in Retinal–Choroidal Vascular Endothelial Cells: Implication for Diabetic Retinopathy Treatment
by: Ying-Jung Hsu, et al.
Published: (2020-08-01)

Comparative study of the effect of atorvastatin and fenofibrate on high-density lipoprotein cholesterol levels in patients with type 2 diabetes
by: Mostafa Najafipour, et al.
Published: (2018-01-01)

Fenofibrate Reduces the Severity of Neuroretinopathy in a Type 2 Model of Diabetes without Inducing Peroxisome Proliferator-Activated Receptor Alpha-Dependent Retinal Gene Expression
by: Jennifer M. Enright, et al.
Published: (2021-12-01)

Complications in diabetes mellitus: diabetic neuropathy focus
by: E. V. Biryukova
Published: (2018-03-01)

Effect of Fenofibrate on Neonatal Hyperbilirubinemia: A Systematic Review and Meta-analysis
by: Nasrin Zamiri-Miandoab, et al.
Published: (2021-07-01)

Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus in Korea
by: Seung-Hyun Ko, et al.
Published: (2012-02-01)

Fenofibrate and Crataegus oxyacantha is an effectual combo for mixed dyslipidemia
by: Huda A Rasheed, et al.
Published: (2020-01-01)

The effect of fenofibrate on early retinal nerve fiber layer loss in type 2 diabetic patients: a case-control study
by: Rui Shi, et al.
Published: (2018-04-01)

A comparative study on the effects of niacin plus atorvastatin with that of fenofibrate plus atorvastatin in dyslipidemia
by: Salim Ahmed, et al.
Published: (2008-06-01)

A comparative study on the effects of niacin plus atorvastatin with that of fenofibrate plus atorvastatin in dyslipidemia
by: Selim Ahmed, et al.
Published: (2008-04-01)

A Rare Cause of Acute Renal Failure: Fenofibrate-Induced Rhabdomyolysis
by: Ferhat Icme, et al.
Published: (2013-08-01)

Pleiotropic effects of PPAR-α – from benchside to bedside
by: I. V. Shirinsky, et al.
Published: (2021-06-01)

Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate
by: Moloud Kazemi, et al.
Published: (2018-01-01)

Fenofibrate-Induced Lichenoid Drug Eruption: A Rare Culprit
by: Fayeza Mohammed, et al.
Published: (2017-11-01)

Detecting responses to treatment with fenofibrate in pedigrees
by: Svetlana Cherlin, et al.
Published: (2018-09-01)

Current state-of-the-art in the safe and efficient management of type 2 diabetes mellitusKey words: diabetes mellitus, vascular complications, glycemia control, management of diabetes mellitus
by: Alexander Sergeevich Ametov, et al.
Published: (2009-06-01)

Total antioxidant blood capacity in patients with type 2 diabetes mellitus and distal symmetrical polyneuropathy
by: Đorđević Gordana, et al.
Published: (2008-01-01)

Residual Cardiovascular Risk in Diabetic Patients: The Role of Fibrate Statin Combination
by: Angelos Liontos, et al.
Published: (2014-10-01)

The lipid-lowering drug fenofibrate combined with si-HOTAIR can effectively inhibit the proliferation of gliomas
by: Wei Zhu, et al.
Published: (2021-06-01)

Anti-atherogenic effects of fibrates in type 2 diabetes
by: Barter Philip
Published: (2001-09-01)

The role of phenofibrate in the treatment of microvascular complications of type 2 diabetes mellitus
by: Larisa Viktorovna Koshel', et al.
Published: (2009-12-01)